Loading
London sarcoma specialist who led TAPPAS, the trial that tested the anti-angiogenic protein TRC105 with pazopanib in angiosarcoma, and who has led many international sarcoma trials.
Robin Jones heads the sarcoma unit at The Royal Marsden and The Institute of Cancer Research. He was first author of the 2022 Journal of Clinical Oncology report of TAPPAS, the phase 3 trial in which adding the endoglin antibody carotuximab (TRC105) to pazopanib did not improve progression-free survival in advanced angiosarcoma. He has been a lead investigator on trials of trabectedin, eribulin and afami-cel in sarcoma.
| Title | Journal | Year |
|---|---|---|
| Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guideline Europe PMC author record matched by affiliation (The Royal Marsden); 742 citations on Europe PMC. | Annals of Oncology | 2021 |
| Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Europe PMC author record matched by affiliation (The Royal Marsden); 471 citations on Europe PMC. | Annals of Oncology | 2018 |
| Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Europe PMC author record matched by affiliation (The Royal Marsden); 452 citations on Europe PMC. | The Lancet | 2016 |
The general principles on the sarcoma subtype pages (reference centre surgery, radiotherapy for high-grade deep tumours, doxorubicin first line, histology-directed later lines) follow this guideline.
One of the most cited papers Europe PMC returns for Robin L. Jones at The Royal Marsden, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Robin L. Jones at The Royal Marsden, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tags sarcoma, trialist.